Albertsons and H&R Block: Two Defensive Consumer Stocks Nobody Is Talking About

Core Insights - Albertsons reported Q3 FY2026 earnings with identical sales growth of 2.4%, primarily driven by the pharmacy segment [1] Company Performance - The growth in identical sales of 2.4% indicates a stable performance in a competitive market, with pharmacy being the main contributor to this growth [1]